from the speedily evolving field of cancer therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is vital for producing productive treatment plans. Among the most promising strategies is using in vitro bystander impact assays, which Engage in a pivotal role in boosting therapeutic efficacy. These assays, prov